Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025)
Verastem's (VSTM) quarterly Other Non-Current Liabilities came in at $35.6 million in Q4 2025, down 38.75% year-on-year from $58.2 million in Q4 2024, and down 26.18% quarter-over-quarter from $48.3 million in Q3 2025.
Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends
Verastem's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $35.6 million for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 38.75% year-over-year to $35.6 million in Q4 2025; TTM through Dec 2025 was $35.6 million, a 38.75% decrease from a year earlier, with the FY2025 full-year figure at $35.6 million, down 38.75% from the prior year.
- Other Non-Current Liabilities eased to $35.6 million in Q4 2025 per VSTM's latest filing, from $48.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $58.2 million in Q4 2024 and bottomed at $51000.0 in Q3 2023.
- The 3-year median for Other Non-Current Liabilities is $35.6 million (2025), against an average of $32.9 million.
- Across the five-year window, Other Non-Current Liabilities surged 51150.98% in 2024 and sank 38.75% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $51000.0 in 2023, then soared by 114015.69% to $58.2 million in 2024, then tumbled by 38.75% to $35.6 million in 2025.
- Per Business Quant, the three latest VSTM Other Non-Current Liabilities figures stand at $35.6 million (Q4 2025), $48.3 million (Q3 2025), and $7.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.65 Mn |
| Sep 30, 2025 | 48.29 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Mar 31, 2025 | 54.75 Mn |
| Dec 31, 2024 | 58.20 Mn |
| Sep 30, 2024 | 26.14 Mn |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2020 | 870,000.00 |
| Mar 31, 2020 | 870,000.00 |
| Dec 31, 2019 | 870,000.00 |
| Sep 30, 2019 | 870,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 1.12 Mn |
| Sep 30, 2018 | 566,000.00 |
| Jun 30, 2018 | 399,000.00 |
| Mar 31, 2018 | 101,000.00 |
| Dec 31, 2017 | 151,000.00 |
| Sep 30, 2017 | 201,000.00 |
| Jun 30, 2017 | 248,000.00 |